Labetuzumab (Anti-CEACAM5 / CEA / CD66e)
Product Specifications
CAS Number
219649-07-7
Additionnal Information
Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA) . It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742216-100 1x 100 µL
CD50 / ICAM3 (CG106), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881925-100 1x 100 µL
P53 Tumor Suppressor Protein (PCRP-TP53-1F7), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681797-500 1x 500 µL
Histone H1 (Nuclear Marker) (r1415-1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681201-100 1x 100 µL
Neurofilament (H+L) (RT-97 + NR-4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details